BCL6 and acute lymphoblastic leukemia: Forced expression of BCL-6 in B-ALL cells sensitized leukemic cells to chemotherapy, suggesting that disrupting B-ALL-osteoblast interaction by targeting BCL-6 could represent a viable treatment strategy [99].